150 related articles for article (PubMed ID: 2906476)
1. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.
Willoughby CP; Cowan RE; Gould SR; Machell RJ; Stewart JB
Scand J Gastroenterol Suppl; 1988; 148():40-4. PubMed ID: 2906476
[TBL] [Abstract][Full Text] [Related]
2. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
Rao SS; Dundas SA; Holdsworth CD; Cann PA; Palmer KR; Corbett CL
Gut; 1989 May; 30(5):675-9. PubMed ID: 2567266
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
Jewell DP; Ireland A
Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
[TBL] [Abstract][Full Text] [Related]
4. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
Ewe K; Eckardt V; Kanzler G
Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
[TBL] [Abstract][Full Text] [Related]
5. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.
Ireland A; Mason CH; Jewell DP
Gut; 1988 Jun; 29(6):835-7. PubMed ID: 2898422
[TBL] [Abstract][Full Text] [Related]
6. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Meyers S; Sachar DB; Present DH; Janowitz HD
Scand J Gastroenterol Suppl; 1988; 148():29-37. PubMed ID: 2906474
[TBL] [Abstract][Full Text] [Related]
7. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
[TBL] [Abstract][Full Text] [Related]
8. Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug disposition.
Hetzel DJ; Shearman DJ; Labrooy J; Bochner F; Imhoff DM; Gibson GE; Fitch RJ; Hecker R; Rowland R
Scand J Gastroenterol Suppl; 1988; 148():61-9. PubMed ID: 3067339
[TBL] [Abstract][Full Text] [Related]
9. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Meyers S; Sachar DB; Present DH; Janowitz HD
Gastroenterology; 1987 Dec; 93(6):1255-62. PubMed ID: 2890550
[TBL] [Abstract][Full Text] [Related]
10. Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschek G; Kruis W
Gut; 1989 Oct; 30(10):1354-61. PubMed ID: 2684804
[TBL] [Abstract][Full Text] [Related]
11. Olsalazine in the treatment of mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind, clinical trial.
Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschegk Y; Kruis W
Scand J Gastroenterol Suppl; 1988; 148():38-9. PubMed ID: 3067338
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.
Kiilerich S; Ladefoged K; Rannem T; Ranløv PJ
Gut; 1992 Feb; 33(2):252-5. PubMed ID: 1347280
[TBL] [Abstract][Full Text] [Related]
13. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
[TBL] [Abstract][Full Text] [Related]
14. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.
Kruis W; Judmaier G; Kayasseh L; Stolte M; Theuer D; Scheurlen C; Hentschel E; Kratochvil P
Eur J Gastroenterol Hepatol; 1995 May; 7(5):391-6. PubMed ID: 7614099
[TBL] [Abstract][Full Text] [Related]
15. Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial.
Ferry GD; Kirschner BS; Grand RJ; Issenman RM; Griffiths AM; Vanderhoof JA; Fiedorek SC; Winter HS; Hassall EG; Watkins JB
J Pediatr Gastroenterol Nutr; 1993 Jul; 17(1):32-8. PubMed ID: 8102399
[TBL] [Abstract][Full Text] [Related]
16. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.
Rijk MC; van Lier HJ; van Tongeren JH
Am J Gastroenterol; 1992 Apr; 87(4):438-42. PubMed ID: 1348159
[TBL] [Abstract][Full Text] [Related]
17. Olsalazine in patients intolerant of sulphasalazine.
Ireland A; Jewell DP
Scand J Gastroenterol; 1987 Nov; 22(9):1038-40. PubMed ID: 2892247
[TBL] [Abstract][Full Text] [Related]
18. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
Rachmilewitz D
BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
[TBL] [Abstract][Full Text] [Related]
19. Different therapy for different types of ulcerative colitis in China.
Jiang XL; Cui HF
World J Gastroenterol; 2004 May; 10(10):1513-20. PubMed ID: 15133864
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Rao SS; Cann PA; Holdsworth CD
Scand J Gastroenterol; 1987 Apr; 22(3):332-6. PubMed ID: 2884724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
